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Salivary sCD14 as a potential biomarker of dental caries 
activity in adults
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CD14 is a co-receptor involved in the recognition of Gram-negative and Gram-positive bacteria, the latter known to cause 
dental caries. The aim of this study was to determine whether soluble CD14 (sCD14) in saliva was associated with caries 
activity and the collection method from the saliva. The study included 55 participants aged 20 to 40 years, 30 with dental 
caries and 25 caries-free controls. We collected 110 saliva samples in total, 55 of resting saliva and 55 of mechanically 
stimulated saliva. Median levels of sCD14, measured with a matrix-matched enzyme-linked immunosorbent assay 
(ELISA), were higher in the caries-active than in the caries-free group in either resting (203.3 vs.167.9 ng mL-1; P<0.01) 
or stimulated saliva (201 vs.105.7 ng mL-1; P<0.01). The resting salivary flow rate was lower in the caries-active than 
caries-free group (0.61±0.42 vs. 0.98±0.52 mL min -1; P<0.01). Hyposalivation was observed only in the caries-active 
group (10 and 13 % in stimulated and resting saliva, respectively). Higher salivary sCD14 levels and secretion rates were 
clearly associated with dental caries and resting saliva. Future studies should focus on the clinical utility of salivary sCD14 
as a potential biomarker and predictor of future caries events.
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Dental caries is the localised destruction of susceptible 
dental hard tissue caused by complex interactions between 
cariogenic bacteria, fermentable carbohydrates, and host 
factors (1, 2). Common virulence factors among the Gram-
negative bacteria are endotoxins (whose biologically active 
components are lipopolysaccharides, LPS) and among the 
Gram-positive bacteria it is the lipoteichoic acid (3, 4). Both 
LPS and lipoteichoic acid bind to the CD14 co-receptor, 
which is a 55-kDa glycoprotein (5). One of the CD14 
functions is to neutralise LPS and other microbial 
constituents (peptidoglycans, lipoteichoic acids) and 
transfer LPS to the transmembrane toll-like receptors 
(TLRs) (6, 7). Depending on the localisation, the CD14 
receptor exists in two forms. The membrane bound CD14 
(mCD14) is expressed on the surface of macrophage-like 
cells (monocyte, macrophage), activated neutrophils, and 
numerous non-myeloid cells including gingival fibroblasts 
(5, 6, 8). The soluble form (sCD14), spontaneously released 
by these cells, circulates in the serum in high amounts 
(2-4 µg mL-1) and interacts with the LPS-binding protein 
(LBP) (9). The LPS/LBP/CD14 ternary complex interacts 
with TLRs, which leads to cell activation (10). Gingival 
epithelial cells, which are the first to encounter periodontal 
pathogens, express mostly TLRs. The bacterial activation 
of TLR-2 and TLR-4 in oral tissue may trigger multiple 
signalling pathways and the synthesis of inflammatory 
cytokines and chemokines that promote destruction of the 
periodontal tissue (11, 12). This highlights the importance 
of monitoring these immunocompounds in dental caries 
development (13, 14).
The prevalence of dental caries in European adults has 
been on a steady rise, urging for better dental caries 
prevention strategies (12). Saliva is essential for caries 
prevention, as it clears the bacterial substrate from dental 
plaque (15, 16), and if salivation is low due to a variety of 
reasons, caries risk increases (17).  Saliva production can 
be reduced by medical treatment (xerogenic drugs), some 
autoimmune diseases (Sjögren’s syndrome, systemic lupus 
erythematosus), dehydration, or head and neck irradiation 
(18, 19). Other factors which influence salivary flow rate 
include age, sex, circadian rhythm, gum chewing, and saliva 
collection methods (16, 19).
However, not only salivary flow or volume can predict 
the risk of caries, but also its immunity markers. The 
problem is, however, that the methods of saliva collection 
are not standardised (20-22), which may affect findings and 
interpretation. Recently, sCD14 was proposed as a salivary 
marker of inflammation in early childhood caries (23). To 
the best of our knowledge, there are no validated and 
commercially available enzyme-linked immunosorbent 
assays (ELISA) to quantify sCD14 in human saliva. 
Furthermore, salivary sCD14 in adults with dental caries 
has poorly been investigated.
The aim of our study was therefore to fill these gaps by 
1) adopting and validating an ELISA to quantify sCD14 
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concentrations in saliva, 2) comparing salivary sCD14 
concentrations under the resting (unstimulated) and 
stimulated conditions, and 3) determining salivary flow 




The study was conducted in Zagreb, Croatia in 2014 
and included 30 dental caries-active and 25 caries-free 
controls. All had signed an informed consent prior to 
enrolment and the study was approved by the ethics 
committee of the Zagreb University School of Dental 
Medicine. The exclusion criteria were deep periodontal 
pockets, acute or chronic inflammation/infection (oral or 
systemic), malignancy, diabetes mellitus, pregnancy, or 
antibiotic therapy. Table 1 shows the demographic, lifestyle, 
and medical information of the enrolled participants.
Sample size estimation
The sample size was calculated based on the sCD14 
concentration as the main outcome measure. All of the 
calculations were based on the two-tailed Mann-Whitney 
U test, assuming the significance level of 0.05 and statistical 
power of 0.8. Based on literature data for resting salivary sCD14 
concentrations of healthy subjects (mean=6.57 ng mL-1, 
SD=3.70) (10), the sample size sufficient to detect a 
meaningful sCD14 increase of at least 50 % in the caries-
active group was calculated to be 22 per group. This sample 
size was also sufficient for stimulated salivary sCD14 (based 
on the estimates in the caries-free group, since there was 
no other literature available). Our sample size (30 in the 
caries-active and 25 in the caries-free group) was therefore 
sufficient to test the hypothesis that sCD14 concentrations 
would vary between these groups. All of the power 
calculations were performed with the G*Power Program, 
version 3.1.9.2 (University of Düsseldorf, Düsseldorf, 
Germany) (24).
Dental examination
All participants were examined by an experienced 
dentist for cavities (as the defining distinction between the 
groups) and clinical symptoms associated with caries: 
gingival bleeding, dryness of mouth, and the burning mouth 
syndrome. The DMFT index was expressed as the sum of 
the number of decayed (D), missing (M), and filled (F) teeth 
according to the criteria defined by the World Health 
Organization (25). To test the reproducibility and agreement 
between the scores, ten participants were examined for tooth 
decay on two separate occasions. The intra-examiner 
reliability had a kappa of 0.857, which indicates a very high 
level of agreement.
Saliva collection
We collected 55 resting and 55 stimulated saliva samples 
between 8–11 am and 2–4 pm. Two hours before collection, 
the participants were asked to refrain from eating, drinking, 
smoking, and brushing teeth to obtain a relatively constant 
baseline. The resting saliva was collected before the 
stimulated one using the passive drool method as described 
earlier (21). The salivary flow rate (mL min-1) was calculated 
from the saliva volume collected over that one minute and 
divided in three categories: very low (<0.1 mL min-1, as a 
diagnostic criterion for hyposalivation), low (0.1–
0.2 mL min-1), and normal (>0.2 mL min-1) (19).
To stimulate salivation, the participants were asked to 
chew 1.5 g of pure paraffin wax (Parafilm®, American 
National Can, Greenwich, CT, USA) for five minutes 
without swallowing. The volume of stimulated saliva was 
then measured as described for the unstimulated saliva 
above and the flow rate calculated. The obtained flow rates 
were divided in three categories: very low (<0.7 mL min-1, 
as diagnostic criterion for hyposalivation), low (0.7–
1.0 mL min-1), and normal (>1.0 mL min-1) (26, 27).
Salivary sCD14 secretion rates (ng min-1) were 
calculated from the saliva volume (mL) in one minute and 
the corresponding sCD14 concentration (ng mL-1).
All saliva samples were collected into sterile plastic 
tubes, and the tubes were capped and immediately stored 
at -20 °C until analysis.
Determination of sCD14 concentration
The concentrations of sCD14 were determined in 
salivary supernatants, obtained by centrifuging the thawed 
saliva samples at 1800 g for 10 min. All supernatants were 
diluted 10 times with assay dilution buffer before analysis. 
The 1:10 dilution gave the best signal-to noise ratio in the 
pre-validation study (results not shown). To eliminate any 
matrix effects, the standards were prepared by mixing 
pooled saliva (9 mL; n=5) of the caries-free subjects and 
the immunoassay buffer (1 mL). Quality controls were 
prepared in a similar manner by diluting the reference 
sample in 90 % saliva. The concentrations of sCD14 were 
determined with the enzyme-linked immunosorbent assay 
(ELISA) using the commercial Enzo Life Science kit 
(Farmingdale, NY, USA; catalogue No. ALX-850-302-
KI01) according to the manufacturer’s instructions. Briefly, 
the 1:10 saliva dilutions, matrix-matched standards, and the 
reference sample were captured on the solid phase by the 
POD-labelled monoclonal antibody specific to human 
sCD14. Five standards (3.12-50 ng mL-1) were used to 
generate the standard curve. When the antibody reacted 
with the substrate tetramethyl benzidine (TMB), we added 
a stop reagent to stop the reaction. The optical absorbance 
of each well was read at 450 nm using a Personal Lab plate 
reader (IASON, Graz Austria). Salivary sCD14 
concentrations were calculated using linear regression 
analysis, multiplied by the dilution factor (10), and 
Prester Lj, et al. Salivary sCD14 as a potential biomarker of dental caries activity in adults 
Arh Hig Rada Toksikol 2017;68:315-321
317
expressed in ng mL-1. All samples were analysed in 
duplicate within three months of collection.
Validation of the salivary sCD14 assay
The assay was validated for both the resting and 
stimulated saliva. Validation included the determination of 
the detection limit (LOD), intra- and inter-assay coefficient 
of variation (CV), and recovery in pooled saliva of five 
healthy subjects. The LOD was calculated as B+3SD, where 
B is the mean of 10 blank measurements, and SD is the 
standard deviation of these measurements. To determine 
intra-assay variation, we analysed one pooled saliva sample 
10 times in a single run and calculated the mean, standard 
deviation, and coefficient of variation. Inter-assay variation 
was calculated based on these 10 measurements of the 
pooled sample over five days. Recovery was calculated by 
standard addition of pool saliva spiked with commercial 
sCD14.
The intra-assay variations for the resting and stimulated 
salivary sCD14 were 5.9 and 8.3 %, respectively. The inter-
assay CVs were 11.6 and 8.9 %, respectively. Mean LOD 
was 4.9 ng mL-1 and mean recovery 86.5 %.
Statistical analysis
The clinical data were tested for normality of distribution 
with the Shapiro-Wilk W test. Non-normally distributed 
variables were compared with the Mann-Whitney U test, 
and the sCD14 concentration and secretion rate data 
obtained from the two collection methods were compared 
with the Wilcoxon matched-pairs signed-rank test. The 
differences between the variables were tested with the chi-
square and Fisher’s exact tests.
The associations between the resting and stimulated 
salivary sCD14 and between sCD14 concentration and 
salivary flow rates were tested with the Spearman’s rank 
correlation coefficient. We considered statistical significance 
for all tests at P<0.05. All of the statistical analyses were 
performed using Dell Statistica, version 13 (Dell Inc., Tulsa, 
TX, USA).
RESULTS
Table 1 summarises and compares the demographic 
data, clinical symptoms, and some lifestyle characteristics 
between the participants with active caries and caries-free 
controls. There were no significant differences in the sex 
ratios, smoking, use of medicines, clinical symptoms of 
caries, or the DMFT index.
Salivary sCD14 concentrations
The caries-active group had significantly higher sCD14 
concentrations both in the resting (P=0.004) and stimulated 
saliva (P=0.001) (Figure 1). Furthermore, sCD14 levels 
differed significantly between the resting and stimulated 
saliva samples in the caries-free controls but not in caries-
active group (P=0.990).
Resting saliva sCD14 significantly correlated with the 
stimulated saliva values (r=0.631, P<0.05).
Salivary flow rates
The caries-active group showed significantly lower 
resting salivary flow than controls (0.61±0.42 vs. 
0.98±0.52 mL min -1; P<0.01). Low salivation (<0.2 mL min-1) 
was found in 26 % of caries-active and 8 % of caries-free 
participants, and hyposalivation (<0.1 mL min-1) was 
established only in the dental caries subjects (13 %) 
(P<0.05).
Stimulated salivary flow rates, however, did not differ 
significantly between the groups (1.33±0.66 mL min-1 in 
the caries-active vs. 1.54±0.63 mL min-1 in the caries-free 
group; P=0.253). Twenty percent in the caries-active and 
8 % in the control group had low salivary flow rate 
(<1.0 mL min-1). As with the resting saliva, hyposalivation 
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Male (n) 11 (37) 9 (36) 0.184
Age (years, range) 31 (22–40) 35 (20–40) 0.540
Non-smokers 17 (68) 17 (57) 0.144
Smokers 8 (32) 13 (43) 0.144
Clinical symptoms
Gingival bleeding on probing 14 (56) 19 (63) 0.388
Dryness of mouth 8 (32) 9 (30) 0.879
Burning mouth syndrome 1 (6) 4 (13) 0.388
Use of medicines 12 (48) 11 (37) 0.152
DMFT index 13.8 (0.1–21) 16.5 (2.0–26) 0.080
Cavities 0 6.8 (1–19) <0.05a
asignificant difference between the groups; DMFT – mean number of decayed, missing, and filled teeth
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Figure 1 Resting and stimulated salivary sCD14 concentrations in caries-active and caries-free participants. The box-
whisker plot shows group medians, interquartile ranges (25–75 %), and the minimum and maximum values. *P=0.004; 
**P=0.001
Figure 2 Resting and stimulated salivary sCD14 secretion rates in the caries-active and caries-free participants. The box-whisker plot 
shows group medians, interquartile ranges (25–75 %), and the minimum and maximum values. *P=0.006; **P=0.008
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was observed only in the caries-active group (10 %) 
(P<0.05).
Correlation between sCD14 and salivary flow rate
We also observed a weak negative correlation between 
sCD14 levels and salivary flow rates in caries-active 
subjects, irrespective of the collection method (r=-0.0896 
to -0.1364; P>0.05).
Salivary sCD14 secretion rates
The two groups did not differ in the median resting 
salivary sCD14 secretion rates (P=0.168), but the caries-
active group had significantly higher sCD14 secretion in 
the stimulated samples (P<0.01) (Figure 2). It also had 
significantly higher sCD14 secretion rates in the stimulated 
than the resting saliva (P<0.01).
DISCUSSION
Our findings have confirmed the hypothesis that sCD14 
would be higher in caries-active than caries-free participants, 
and may suggest that the presence of dental caries is an 
important factor associated with salivary sCD14 levels. To 
the best of our knowledge, these are the first findings in 
adults, as earlier studies were focused on children (12, 23). 
Except in saliva, elevated sCD14 levels were reported in 
the serum of patients with chronic periodontitis (28, 29).
This brings us to another novelty of our research. 
Salivary immunoassays are often performed with the 
commercial kits designed for serum analysis. To the best 
of our knowledge, we have been the first to validate the 
ELISA for salivary sCD14 following the general 
recommendations by Jaedicke et al. (30) for validating 
ELISAs for the use with human saliva samples. Compared 
to serum analysis, our salivary sCD14 concentrations were 
approximately 20 times lower. However, the commercial 
ELISA was highly sensitive, and with slight modifications 
it was able to detect sCD14 in saliva. Similarly, Browne et 
al. (31) managed to repurpose some commercial 
immunoassays for the detection of several cytokines and 
chemokines in serum for their accurate quantification in 
saliva.
Our study has also confirmed the association between 
chronically low salivary flow rate and dental caries (32, 
33).The prevalence of low salivary flow was 20-26 % 
(depending on the collection method) in the caries-active 
group and 8 % in the controls. In other words, the risk of 
caries was about three times higher irrespective of the saliva 
collection method. Furthermore, hyposalivation was 
observed only in the caries-active group (10–13 % 
prevalence, depending on the saliva collection method). 
The prevalence of hyposalivation in the general population 
adults is high (10.9–17.8 % in the resting and 0–5.5 % in 
stimulated saliva) (34), which may give the reader an idea 
of the possible risk of caries in the general population.
We observed two interesting findings related to the 
salivary sCD14 secretion rates. They did not differ between 
the resting and stimulated saliva in controls (P=0.168) but 
soared significantly with stimulation in the caries-active 
group (P<0.01) (Figure 2). Does stimulation, therefore, set 
in motion mechanisms that mobilise pooled sCD14 and 
therefore reflect more truthfully the existing inflammation? 
This question remains to be answered in future studies. 
Another issue that needs addressing is the lack of a 
standardised procedure for routine saliva analysis in a 
clinical laboratory (32, 35).
In conclusion, our findings highlight the diagnostic 
potential of saliva. We have demonstrated that matrix-
matched immunoassay for sCD14 quantification produced 
an acceptable analytical performance. Salivary sCD14 
concentrations were significantly higher in the caries-active 
group than controls in both resting and stimulated saliva. 
Dental carries seems to affect both the salivary flow rate 
and salivary secretion rate. Future research should confirm 
the role of sCD14 in dental caries development and focus 
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sCD14 u slini kao biljeg aktivnosti zubnoga karijesa u odraslih
CD14 je koreceptor uključen u prepoznavanje Gram-negativnih i Gram-pozitivnih bakterija. Cilj ovoga istraživanja bio 
je ispitati povezanost između aktivnosti zubnoga karijesa i razine topivoga CD14 (sCD14) u slini odraslih osoba. Također 
smo ispitali utjecaj metode skupljanja sline na koncentraciju sCD14. U istraživanju je sudjelovalo 55 ispitanika u dobi 
od 20 do 40 godina: 30 ispitanika sa zubnim karijesom i 25 bez karijesa (kontrola). Ukupno smo skupili 110 uzoraka: 55 
nestimulirane i 55 mehanički stimulirane sline. Medijan koncentracije sCD14 u slini, izmjerene enzim-imunokemijskom 
metodom (ELISA), bio je viši u ispitanika s karijesom, i to u nestimuliranoj (203,3 prema 167,9 ng mL-1, P<0,01) kao 
i u stimuliranoj slini (201 prema 105,7 ng mL-1, P<0,01) u usporedbi s kontrolnom skupinom. Ustanovljena je značajno 
niža razina lučenja sline u ispitanika s karijesom negoli u kontrolnoj skupini (0,61 ± 0,42 prema 0,98 ± 0,52 mL min-1, 
P<0,01). Hiposalivacija je ustanovljena samo u skupini sa zubnim karijesom (10-13 % u stimuliranoj i nestimuliranoj 
slini). Ustanovili smo da koncentracija sCD14 u slini, kao i brzina protoka sline, ovisi o metodi skupljanja sline i aktivnosti 
zubnoga karijesa. Klinička primjena određivanja koncentracije sCD14 kao potencijalnoga biljega i prediktora upale kod 
zubnoga karijesa trebala bi se dalje ispitati.
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